Generic Name and Formulations:
Atenolol, chlorthalidone; 50mg/25mg+, 100mg/25mg; tabs; (+) scored.
Indications for TENORETIC:
Switching from monotherapy: initially one 50mg/25mg tab daily; may increase to one 100mg/25mg tab daily. CrCl 15–35mL/minute: max 50mg atenolol/day. CrCl <15mL/minute: max 50mg atenolol every other day.
Sinus bradycardia. 2nd- or 3rd-degree AV block. Overt heart failure. Cardiogenic shock. Anuria. Sulfonamide allergy. Pregnancy (Cat.D).
Heart failure. Bronchospastic disease. Renal or hepatic dysfunction. SLE. Gout. Diabetes. Asthma. Hyperthyroidism. Hypokalemia. Surgery. Postsympathectomy. Peripheral circulatory disorders. Avoid abrupt cessation. Monitor electrolytes. Excessive diuresis. Potassium supplementation may be needed. Nursing mothers: not recommended.
May potentiate hypotension with prazosin, alcohol, catecholamine-depleting drugs, CNS depressants. May increase toxicity of diazoxide, digitalis, lithium. Conduction abnormalities, bradycardia, heart block with calcium channel blockers (esp. verapamil, diltiazem). Adjust antidiabetic medications. Increased rebound hypertension with clonidine withdrawal. May block epinephrine. May increase responsiveness to tubocurarine. ACTH, steroids, amphotericin B increase risk of hypokalemia.
Cardioselective beta-blocker + diuretic.
Heart failure, bronchospasm, bradycardia, heart block, dizziness, fatigue, fluid or electrolyte imbalance, hyperuricemia, orthostatic hypotension, GI upset, cold extremities.
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Undifferentiated Headaches Common in Children, Adolescents
- Smoking Associated With Increased Relapse Rate in Interferon Beta-Treated Relapsing-Remitting MS
- Frontotemporal Dementia, Frontotemporal Lobar Degeneration Symptoms More Common Later in Life
- No Reduction in Cerebral Perfusion With Intensive Blood Pressure Lowering
- Successful Delirium Prevention in Critically Ill With Dexmedetomidine